Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis.

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmogenic disease occurring in patients with a structurally normal heart: the disease is characterized by life-threatening arrhythmias elicited by stress and emotion. In 2001, the ryanodine receptor was identified as the gene that is linked to CPVT; shortly thereafter, cardiac calsequestrin was implicated in the recessive form of the same disease. It became clear that abnormalities in intracellular Ca(2+) regulation could profoundly disrupt the electrophysiological properties of the heart. In this article, we discuss the molecular basis of the disease and the pathophysiological mechanisms that are impacting clinical diagnosis and management of affected individuals. As of today, the interaction between basic scientists and clinicians to understand CPVT and identify new therapeutic strategies is one of the most compelling examples of the importance of translational research in cardiology.

[1]  Donald M. Bers,et al.  Ca2+ Scraps: Local Depletions of Free [Ca2+] in Cardiac Sarcoplasmic Reticulum During Contractions Leave Substantial Ca2+ Reserve , 2003, Circulation research.

[2]  M. Yano,et al.  Catecholaminergic Polymorphic Ventricular Tachycardia Is Caused by Mutation-Linked Defective Conformational Regulation of the Ryanodine Receptor , 2010, Circulation research.

[3]  Z. Kubalová,et al.  Modulation of cytosolic and intra‐sarcoplasmic reticulum calcium waves by calsequestrin in rat cardiac myocytes , 2004, The Journal of physiology.

[4]  D. Stephan,et al.  Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). , 2001, Human molecular genetics.

[5]  Lai-Hua Xie,et al.  Arrhythmogenic consequences of intracellular calcium waves. , 2009, American journal of physiology. Heart and circulatory physiology.

[6]  Edward G Lakatta,et al.  A coupled SYSTEM of intracellular Ca2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart's pacemaker. , 2010, Circulation research.

[7]  E. Marbán,et al.  Mechanisms of arrhythmogenic delayed and early afterdepolarizations in ferret ventricular muscle. , 1986, The Journal of clinical investigation.

[8]  H. Duff,et al.  Skeletal and cardiac ryanodine receptors exhibit different responses to Ca2+ overload and luminal ca2+. , 2007, Biophysical journal.

[9]  Wei Zhang,et al.  Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy , 2006, Proceedings of the National Academy of Sciences.

[10]  R. Körfer,et al.  Composite polymorphisms in the ryanodine receptor 2 gene associated with arrhythmogenic right ventricular cardiomyopathy. , 2006, Cardiovascular research.

[11]  Tao Yang,et al.  Modest Reductions of Cardiac Calsequestrin Increase Sarcoplasmic Reticulum Ca2+ Leak Independent of Luminal Ca2+ and Trigger Ventricular Arrhythmias in Mice , 2007, Circulation research.

[12]  A. J. Williams,et al.  Regulation of Current Flow through Ryanodine Receptors by Luminal Ca2+ , 1997, The Journal of Membrane Biology.

[13]  S. Priori,et al.  Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation. , 2010, Cardiovascular research.

[14]  S. Reiken,et al.  Sudden Death in Familial Polymorphic Ventricular Tachycardia Associated With Calcium Release Channel (Ryanodine Receptor) Leak , 2004, Circulation.

[15]  C. Valdivia,et al.  Direct binding of verapamil to the ryanodine receptor channel of sarcoplasmic reticulum. , 1990, Biophysical journal.

[16]  A. Fabiato,et al.  Two kinds of calcium-induced release of calcium from the sarcoplasmic reticulum of skinned cardiac cells. , 1992, Advances in experimental medicine and biology.

[17]  D. Tester,et al.  Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases. , 2004, Mayo Clinic proceedings.

[18]  S. Priori,et al.  Luminal Ca2+ Regulation of Single Cardiac Ryanodine Receptors: Insights Provided by Calsequestrin and its Mutants , 2008, The Journal of general physiology.

[19]  G. Danieli,et al.  Juvenile sudden death in a family with polymorphic ventricular arrhythmias caused by a novel RyR2 gene mutation: evidence of specific morphological substrates. , 2005, Human pathology.

[20]  Y. Shimoni,et al.  K201 (JTV519) suppresses spontaneous Ca2+ release and [3H]ryanodine binding to RyR2 irrespective of FKBP12.6 association. , 2007, The Biochemical journal.

[21]  Michael J Ackerman,et al.  Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing. , 2005, Heart rhythm.

[22]  N. Demaurex,et al.  Endoplasmic reticulum Ca2+ measurements reveal that the cardiac ryanodine receptor mutations linked to cardiac arrhythmia and sudden death alter the threshold for store-overload-induced Ca2+ release. , 2008, The Biochemical journal.

[23]  H. Nishio,et al.  Postmortem molecular screening for cardiac ryanodine receptor type 2 mutations in sudden unexplained death: R420W mutated case with characteristics of status thymico-lymphatics. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[24]  Sandor Györke,et al.  The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium. , 2004, Biophysical journal.

[25]  David W Piston,et al.  Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass. , 2010, Journal of molecular and cellular cardiology.

[26]  F. Protasi,et al.  Ca2+ influx through alpha1S DHPR may play a role in regulating Ca2+ release from RyR1 in skeletal muscle. , 2004, American journal of physiology. Cell physiology.

[27]  D. Roden,et al.  Casq 2 deletion causes sarcoplasmic reticulum volume increase , premature Ca 2 + release , and catecholaminergic polymorphic ventricular tachycardia , 2006 .

[28]  D. Burkhoff,et al.  PKA Phosphorylation Dissociates FKBP12.6 from the Calcium Release Channel (Ryanodine Receptor) Defective Regulation in Failing Hearts , 2000, Cell.

[29]  E. Lakatta,et al.  Spontaneous Myocardial Calcium Oscillations: , 1993, Journal of cardiovascular electrophysiology.

[30]  D. Bers,et al.  Potentiation of fractional sarcoplasmic reticulum calcium release by total and free intra-sarcoplasmic reticulum calcium concentration. , 2000, Biophysical journal.

[31]  S. Priori,et al.  Unexpected Structural and Functional Consequences of the R33Q Homozygous Mutation in Cardiac Calsequestrin: A Complex Arrhythmogenic Cascade in a Knock In Mouse Model , 2008, Circulation research.

[32]  L. Toivonen,et al.  Calcium Channel Antagonism Reduces Exercise‐Induced Ventricular Arrhythmias in Catecholaminergic Polymorphic Ventricular Tachycardia Patients with RyR2 Mutations , 2005, Journal of cardiovascular electrophysiology.

[33]  Filip Van Petegem,et al.  The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule , 2010, Nature.

[34]  E. Schulze-Bahr,et al.  The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handling. , 2010, Journal of molecular and cellular cardiology.

[35]  N. Ikemoto,et al.  Postulated role of inter-domain interaction within the ryanodine receptor in Ca(2+) channel regulation. , 2000, Trends in cardiovascular medicine.

[36]  D. Roden,et al.  Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans , 2009, Nature Medicine.

[37]  D. Roden,et al.  Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. , 2006, The Journal of clinical investigation.

[38]  B. Knollmann.  New roles of calsequestrin and triadin in cardiac muscle , 2009, The Journal of physiology.

[39]  Dmitry Terentyev,et al.  Modulation of SR Ca release by luminal Ca and calsequestrin in cardiac myocytes: effects of CASQ2 mutations linked to sudden cardiac death. , 2008, Biophysical journal.

[40]  H. Duff,et al.  Caffeine induces Ca2+ release by reducing the threshold for luminal Ca2+ activation of the ryanodine receptor. , 2008, The Biochemical journal.

[41]  C. Ward,et al.  Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. , 2008, The Journal of clinical investigation.

[42]  J. Seidman,et al.  Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia. , 2007, The Journal of clinical investigation.

[43]  E. Lakatta.  Functional implications of spontaneous sarcoplasmic reticulum Ca2+ release in the heart. , 1992, Cardiovascular research.

[44]  A. Fabiato,et al.  Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. , 1983, The American journal of physiology.

[45]  P. Coumel.  Catecholamine-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children : report of four cases , 1978 .

[46]  E. Lee,et al.  Genetic variability of RyR2 and CASQ2 genes in an Asian population. , 2009, Forensic science international.

[47]  M. Ikura,et al.  Crystal structure of type I ryanodine receptor amino-terminal β-trefoil domain reveals a disease-associated mutation “hot spot” loop , 2009, Proceedings of the National Academy of Sciences.

[48]  D. Lancet,et al.  A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. , 2001, American journal of human genetics.

[49]  S. Priori,et al.  FKBP12.6 Deficiency and Defective Calcium Release Channel (Ryanodine Receptor) Function Linked to Exercise-Induced Sudden Cardiac Death , 2003, Cell.

[50]  D. Bers.  Calcium and cardiac rhythms: physiological and pathophysiological. , 2002, Circulation research.

[51]  A. J. Williams,et al.  Evidence for Ca(2+) activation and inactivation sites on the luminal side of the cardiac ryanodine receptor complex. , 2000, Circulation research.

[52]  Dmitry Terentyev,et al.  Modulation of ryanodine receptor by luminal calcium and accessory proteins in health and cardiac disease. , 2008, Cardiovascular research.

[53]  S. Huke,et al.  Kinetics of FKBP12.6 Binding to Ryanodine Receptors in Permeabilized Cardiac Myocytes and Effects on Ca Sparks , 2010, Circulation research.

[54]  C. H. George,et al.  Ryanodine Receptor Mutations Associated With Stress-Induced Ventricular Tachycardia Mediate Increased Calcium Release in Stimulated Cardiomyocytes , 2003, Circulation research.

[55]  D. Terentyev,et al.  A mutation in calsequestrin, CASQ2D307H, impairs Sarcoplasmic Reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice. , 2007, Cardiovascular research.

[56]  M. Yano,et al.  Identification of Target Domains of the Cardiac Ryanodine Receptor to Correct Channel Disorder in Failing Hearts , 2008, Circulation.

[57]  S. Priori,et al.  Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia , 2001, Circulation.

[58]  Shi-Xian Deng,et al.  Protection from Cardiac Arrhythmia Through Ryanodine Receptor-Stabilizing Protein Calstabin2 , 2004, Science.

[59]  Heping Cheng,et al.  Calcium sparks. , 2008, Physiological reviews.

[60]  M. Diaz,et al.  The effects of low concentrations of caffeine on spontaneous Ca release in isolated rat ventricular myocytes. , 2000, Cell calcium.

[61]  S. Priori,et al.  Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia. , 2011, Journal of molecular and cellular cardiology.

[62]  D. Allen,et al.  Oscillations of intracellular Ca2+ in mammalian cardiac muscle , 1983, Nature.

[63]  G. Danieli,et al.  The binding of the RyR2 calcium channel to its gating protein FKBP12.6 is oppositely affected by ARVD2 and VTSIP mutations. , 2002, Biochemical and biophysical research communications.

[64]  Carlo Napolitano,et al.  Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia , 2002, Circulation.

[65]  Subash C. Gupta,et al.  The Catecholaminergic Polymorphic Ventricular Tachycardia Mutation R33Q Disrupts the N-terminal Structural Motif That Regulates Reversible Calsequestrin Polymerization* , 2010, The Journal of Biological Chemistry.

[66]  P. Coumel,et al.  Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. , 1995, Circulation.

[67]  M. Nagashima,et al.  Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death , 2003, Heart.

[68]  J. Kere,et al.  Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. , 1999, Journal of the American College of Cardiology.

[69]  A. Wilde,et al.  Expanding Spectrum of Human RYR2-Related Disease: New Electrocardiographic, Structural, and Genetic Features , 2007, Circulation.

[70]  H. Duff,et al.  Removal of FKBP12.6 Does Not Alter the Conductance and Activation of the Cardiac Ryanodine Receptor or the Susceptibility to Stress-induced Ventricular Arrhythmias* , 2007, Journal of Biological Chemistry.

[71]  Sara Negri,et al.  Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model. , 2006, Circulation research.

[72]  D M Bers,et al.  Sarcoplasmic reticulum Ca(2+) release causes myocyte depolarization. Underlying mechanism and threshold for triggered action potentials. , 2000, Circulation research.

[73]  I. V. van Langen,et al.  A Case of Catecholaminergic Polymorphic Ventricular Tachycardia Caused by Two Calsequestrin 2 Mutations , 2008, Pacing and clinical electrophysiology : PACE.

[74]  A. Wilde,et al.  Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients , 2005, Journal of Medical Genetics.

[75]  P B Corr,et al.  Mechanisms underlying early and delayed afterdepolarizations induced by catecholamines. , 1990, The American journal of physiology.

[76]  Carlo Napolitano,et al.  Increased Ca2+ Sensitivity of the Ryanodine Receptor Mutant RyR2R4496C Underlies Catecholaminergic Polymorphic Ventricular Tachycardia , 2009, Circulation research.

[77]  L. Xu,et al.  Regulation of cardiac muscle Ca2+ release channel by sarcoplasmic reticulum lumenal Ca2+. , 1998, Biophysical journal.

[78]  S. Priori,et al.  Molecular and Electrophysiological Bases of Catecholaminergic Polymorphic Ventricular Tachycardia , 2007, Journal of cardiovascular electrophysiology.

[79]  M. Scheinman,et al.  [A Novel mutation of F189L in CASQ2 in families with catecholaminergic polymorphic ventricular tachycardia]. , 2008, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[80]  D. Laver.  Ca2+ stores regulate ryanodine receptor Ca2+ release channels via luminal and cytosolic Ca2+ sites. , 2007, Biophysical journal.

[81]  M. Varsányi,et al.  Characterization of human cardiac calsequestrin and its deleterious mutants. , 2007, Journal of molecular biology.

[82]  M. Diaz,et al.  Modulation of CICR has no maintained effect on systolic Ca2+: simultaneous measurements of sarcoplasmic reticulum and sarcolemmal Ca2+ fluxes in rat ventricular myocytes , 2000, The Journal of physiology.

[83]  W. Lederer,et al.  The Ca 2+ leak paradox and rogue ryanodine receptors: SR Ca 2+ efflux theory and practice. , 2006, Progress in biophysics and molecular biology.

[84]  A. Leenhardt,et al.  Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia , 2009, Circulation.

[85]  Michael J Ackerman,et al.  The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis. , 2009, Journal of the American College of Cardiology.

[86]  S. Priori,et al.  Catecholaminergic polymorphic ventricular tachycardia-related mutations R33Q and L167H alter calcium sensitivity of human cardiac calsequestrin. , 2008, The Biochemical journal.

[87]  D. Bers,et al.  Spontaneous Ca waves in ventricular myocytes from failing hearts depend on Ca(2+)-calmodulin-dependent protein kinase II. , 2010, Journal of molecular and cellular cardiology.

[88]  M. Diaz,et al.  The control of Ca release from the cardiac sarcoplasmic reticulum: regulation versus autoregulation. , 1998, Cardiovascular research.

[89]  Heping Cheng,et al.  RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR). , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[90]  H. Wellens,et al.  Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes: time to revise current concepts. , 2000, Cardiovascular research.

[91]  A. Tripathy,et al.  Sarcoplasmic reticulum lumenal Ca2+ has access to cytosolic activation and inactivation sites of skeletal muscle Ca2+ release channel. , 1996, Biophysical journal.

[92]  N. Kaneko.  New 1,4‐benzothiazepine derivative, K201, demonstrates cardioprotective effects against sudden cardiac cell death and intracellular calcium blocking action , 1994 .

[93]  L. Wilson,et al.  Spontaneous calcium release in tissue from the failing canine heart. , 2009, American journal of physiology. Heart and circulatory physiology.

[94]  F. van Petegem,et al.  Crystal structures of the N-terminal domains of cardiac and skeletal muscle ryanodine receptors: insights into disease mutations. , 2009, Structure.

[95]  D. Bers,et al.  Cellular basis of triggered arrhythmias in heart failure. , 2004, Trends in cardiovascular medicine.

[96]  R. Tsien,et al.  Cellular and subcellular mechanisms of cardiac pacemaker oscillations. , 1979, The Journal of experimental biology.

[97]  W. Lederer,et al.  The Ca2+ leak paradox and “rogue ryanodine receptors”: SR Ca2+ efflux theory and practice , 2006 .

[98]  J. Lupski,et al.  Mechanisms for human genomic rearrangements , 2008, PathoGenetics.

[99]  D. Bers.  Cardiac excitation–contraction coupling , 2002, Nature.

[100]  D. Laver.  Ca2+ STORES REGULATE RYANODINE RECEPTOR Ca2+ RELEASE CHANNELS VIA LUMINAL AND CYTOSOLIC Ca2+ SITES , 2007, Clinical and experimental pharmacology & physiology.

[101]  D. Maclennan,et al.  Mechanistic models for muscle diseases and disorders originating in the sarcoplasmic reticulum. , 2011, Biochimica et biophysica acta.

[102]  Huihui Kong,et al.  Enhanced Store Overload–Induced Ca2+ Release and Channel Sensitivity to Luminal Ca2+ Activation Are Common Defects of RyR2 Mutations Linked to Ventricular Tachycardia and Sudden Death , 2005, Circulation research.

[103]  S. Priori,et al.  Clinical Phenotype and Functional Characterization of CASQ2 Mutations Associated With Catecholaminergic Polymorphic Ventricular Tachycardia , 2006, Circulation.

[104]  M. Diaz,et al.  Measurement of sarcoplasmic reticulum Ca2+ content and sarcolemmal Ca2+ fluxes in isolated rat ventricular myocytes during spontaneous Ca2+ release , 1997, The Journal of physiology.

[105]  M. Yano,et al.  Defective domain-domain interactions within the ryanodine receptor as a critical cause of diastolic Ca2+ leak in failing hearts. , 2008, Cardiovascular research.

[106]  Alan Garfinkel,et al.  Spark-Induced Sparks As a Mechanism of Intracellular Calcium Alternans in Cardiac Myocytes , 2010, Circulation research.

[107]  M. Viitasalo,et al.  Search for cardiac calcium cycling gene mutations in familial ventricular arrhythmias resembling catecholaminergic polymorphic ventricular tachycardia , 2009, BMC Medical Genetics.

[108]  I. Györke,et al.  Regulation of the cardiac ryanodine receptor channel by luminal Ca2+ involves luminal Ca2+ sensing sites. , 1998, Biophysical journal.